1. Tetracyclines promote survival and fitness in mitochondrial disease models.
- Author
-
Perry EA, Bennett CF, Luo C, Balsa E, Jedrychowski M, O'Malley KE, Latorre-Muro P, Ladley RP, Reda K, Wright PM, Gygi SP, Myers AG, and Puigserver P
- Subjects
- Activating Transcription Factor 4 metabolism, Animals, Brain pathology, Cells, Cultured, Disease Models, Animal, Electron Transport Complex I genetics, Electron Transport Complex I metabolism, High-Throughput Screening Assays, Humans, Leigh Disease drug therapy, Leigh Disease pathology, Life Expectancy, Metabolomics, Mice, Mice, Knockout, Mitochondrial Diseases mortality, Mitochondrial Diseases pathology, Physical Fitness, Survival Analysis, Anti-Bacterial Agents therapeutic use, Mitochondrial Diseases drug therapy, Tetracyclines therapeutic use
- Abstract
Mitochondrial diseases (MDs) are a heterogeneous group of disorders resulting from mutations in nuclear or mitochondrial DNA genes encoding mitochondrial proteins
1,2 . MDs cause pathologies with severe tissue damage and ultimately death3,4 . There are no cures for MDs and current treatments are only palliative5-7 . Here we show that tetracyclines improve fitness of cultured MD cells and ameliorate disease in a mouse model of Leigh syndrome. To identify small molecules that prevent cellular damage and death under nutrient stress conditions, we conduct a chemical high-throughput screen with cells carrying human MD mutations and discover a series of antibiotics that maintain survival of various MD cells. We subsequently show that a sub-library of tetracycline analogues, including doxycycline, rescues cell death and inflammatory signatures in mutant cells through partial and selective inhibition of mitochondrial translation, resulting in an ATF4-independent mitohormetic response. Doxycycline treatment strongly promotes fitness and survival of Ndufs4-/- mice, a preclinical Leigh syndrome mouse model8 . A proteomic analysis of brain tissue reveals that doxycycline treatment largely prevents neuronal death and the accumulation of neuroimmune and inflammatory proteins in Ndufs4-/- mice, indicating a potential causal role for these proteins in the brain pathology. Our findings suggest that tetracyclines deserve further evaluation as potential drugs for the treatment of MDs.- Published
- 2021
- Full Text
- View/download PDF